Phase II trial as new adjuvant chemotherapy regimen for capecitabine in stage II and III colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2019
Price : $35 *
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 18 Jan 2019 Status changed from active, no longer recruiting to completed.
- 13 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 05 Aug 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan